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Alcohol-Related Morbidity

and Mortality

Jürgen Rehm, Ph.D., Gerhard Gmel, Ph.D., Christopher T. Sempos, Ph.D., and 
Maurizio Trevisan, M.D., M.S. 
Alcohol use is related to a wide variety of negative health outcomes including morbidity, 
mortality, and disability. Research on alcohol-related morbidity and mortality takes into 
account the varying effects of overall alcohol consumption and drinking patterns. The results 
from this epidemiological research indicate that alcohol use increases the risk for many 
chronic health consequences (e.g., diseases) and acute consequences (e.g., traffic crashes), 
but a certain pattern of regular light-to-moderate drinking may have beneficial effects on 
coronary heart disease. Several issues are relevant to the methodology of studies of alcohol-
related morbidity and mortality, including the measurement of both alcohol consumption 
and the outcomes studied as well as study design. Broad summary measures that reflect 
alcohol’s possible effects on morbidity, mortality, and disability may be more useful than 
measures of any one outcome alone. KEY WORDS: AODR (alcohol and other drug related) 
mortality; morbidity; epidemiological indicators; chronic AODE (alcohol and other drug effects); 
acute AODE; amount of AOD use; alcoholic beverage; heart disorder; meal and meal time 
Alcohol use contributes to a range of acute and chronic health consequences, from 
injuries resulting from traffic crashes 
to cancer and cardiovascular disease. 
Research has explored the relation-
ships between the risk for alcohol-
related morbidity and mortality and 
both the overall amount of alcohol 
consumed and the pattern of drink­
ing. This article will review this 
research, with a focus on the relation-
ship between alcohol use and coro­
nary heart disease (CHD). 
Alcohol-related mortality is stud­
ied more frequently than alcohol-
related morbidity. More than 80 
studies have examined the relation-
ship between a person’s average vol­
ume of alcohol consumption (i.e., 
average number of drinks per day) 
and alcohol-related mortality (see 
Rehm et al. 2001b for a meta-analysis 
of studies conducted through 1999). 
Research has linked varying average 
levels of alcohol consumption (i.e., 
light, moderate, heavy) to increased 
and sometimes decreased risk for 
morbidity and mortality related to 
more than 60 disease conditions 
(English et al. 1995; Single et al. 
1999; Gutjahr et al. 2001; Ridolfo 
and Stevenson 2001; Rehm et al. in 
press b). Some of these research find­
ings are reflected in the table accom­
panying this article. 
Fewer studies examine alcohol-
related morbidity alone or a combi­
nation of morbidity and mortality. 
One study that grouped morbidity 
and mortality together examined the 
impact of alcohol on coronary heart 
disease (CHD)(Rehm et al. 1997); in 
this study, which used data from the 
National Health and Nutrition 
Examination Epidemiologic Follow-
Up Study, based on a large represen­
tative survey of the U.S. general pop­
ulation, the data did not distinguish 
between people newly diagnosed with 
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CHD and people who had died of 
the disorder. Overall, information about 
alcohol-related morbidity alone is 
limited because studies with morbidity 
as the endpoint demand substantial 
resources to assess individual outcomes 
in an objective and standardized way. 
Even scarcer than studies of alcohol-
related morbidity are studies of the 
effects of alcohol consumption on dis­
ability or quality of life (i.e., how 
alcohol use causes health-related activ­
ity limitations, as defined in the Inter-
national Classification of Functioning, 
Disability and Health (World Health 
Organization [WHO] 2001). The lack 
of studies linking alcohol use to dis­
ability or quality of life is on the one 
hand surprising, as the first global study 
of alcohol-related morbidity and mor­
tality clearly indicated that alcohol 
causes a larger proportion of global 
disability than global mortality. Speci­
fically, it found that 1.5 percent of all 
deaths were attributable to alcohol, but 
6 percent of all life years lost to dis­
ability were attributable to alcohol (Mur­
ray and Lopez 1996). On the other 
hand, even in developed countries, 
investigators do not collect as much 
data on disability as they do on mor­
tality, because mortality is easier to 
quantify and data recording is re­
quired by law (i.e., a death certificate 
must be filled out in a standardized 
way) (Goerdt et al. 1996; see also 
Rehm and Gmel 2000). Unlike the 
registration of deaths, there is no rou­
tine registration of disability, which 
would allow relatively easy access for 
research purposes, linking other data 
such as alcohol use to disability end-
points. That is, if a disability registra­
tion existed, researchers could more 
easily study the link between alcohol 
use and disability. As a result, studies 
on disability are harder to conduct 
and require more resources. Despite 
these challenges, disability and quality 
of life have been receiving increasing 
attention as health outcomes, both 
subjectively and as part of summary 
measures of health (i.e., measures that 
integrate effects on morbidity, mortality, 
and disability) (Murray et al. 2000). 
The following sections examine 
the possible chronic and acute health 
consequences of alcohol use, focusing 
on the example of CHD. This review 
does not examine alcohol’s role in the 
social, legal, and financial consequences 
of alcohol use and alcohol-related 
injury, as this subject is covered else-
where (see Rehm 20051; Klingemann 
and Gmel 2001; see also the article 
by Gmel and Rehm in this issue). 
Chronic Consequences of 
Alcohol Use 
The table gives an overview of the 
risks for major chronic diseases relat­
ed to varying levels of alcohol con­
sumption, based on the results of 
observational data from cohort and 
case control studies that mainly used 
mortality as an endpoint. Because 
data on morbidity alone are not suffi­
ciently available for most disease con­
ditions (Single et al. 1999), meta­
analyses usually combine mortality 
and morbidity as endpoints. In cohort 
studies, researchers evaluate a group 
of people, known as a cohort, who 
are disease free at the beginning of 
the study, to assess if they have been 
exposed to potential risk factors. The 
cohort is then followed over time and 
monitored for the occurrence of dis­
ease endpoints and, in some studies, 
changes in risk factor exposure. The 
objective is to assess which risk fac­
tors are related to the risk of develop­
ing a disease or condition. The pur­
pose of case control studies is to assess 
whether people affected by a disease 
(i.e., cases) are more or less likely 
than a comparable group of people 
who do not have the disease (i.e., 
control subjects) to have been exposed 
to the relevant risk factors before devel­
oping the disease (see Gordis 1999). 
In the table, relative risk estimates 
are shown to quantify the effect size 
of the risk relationships. For example, 
females in drinking category I, who 
drink on average up to 20 grams of 
pure alcohol per day,1 have a relative 
risk of 1.14, compared with female 
abstainers, of developing breast can­
cer. A relative risk of 1.14 corresponds 
to a 14-percent higher risk. For 
females drinking more than 40 grams 
of pure alcohol per day (drinking cat­
egory III), the relative risk is 1.59, or 
about one and one-half times as large 
as for female abstainers, and corre­
sponds to a 59-percent risk increase. 
The International Classification of 
Diseases (ICD) is a system for coding 
both nonfatal and fatal events. Under 
the ICD system, the medical infor­
mation provided on the death certifi­
cate, for example, is coded to indicate 
the underlying cause of death. The 
table shows the ICD codes from the 
9th and 10th editions of the ICD for 
each disease group (WHO 1977, 1992). 
As shown in the table, research has 
demonstrated that, for many chronic 
diseases, the risk of disease increases 
with increasing average daily alcohol 
consumption. Most of the major dis­
ease categories listed in the table have 
not been linked to specific patterns of 
drinking. However, this may be the 
result of the lack of investigation into 
such relationships. For example, 
although researchers have speculated 
that breast cancer risk may be influ­
enced by the frequency of heavy 
drinking episodes (defined as the 
consumption of more than five 
drinks on one occasion without regu­
larly drinking this amount), no 
research has explored this relationship 
(Kohlmeier and Mendez 1997). One 
disease risk that is clearly affected by 
the pattern of alcohol consumption is 
the risk for cardiovascular disease 
(CVD), especially CHD (see below). 
Alcohol Consumption, Coronary 
Heart Disease, and Other 
Cardiovascular Outcomes 
Average Light-to-Moderate Drinking. 
The most comprehensive meta-analysis 
on average consumption and CHD 
found that this relationship was 
represented by a J-shaped curve (see 
the accompanying figure) (Corrao et 
al. 2000). That is, compared with absti­
nence from alcohol, low-to-moderate 
average consumption of alcohol is 
1In the United States, a drink is considered to be 0.5 
ounces (oz) or 15 grams of alcohol, which is equivalent to 
12 oz (355 milliliters [mL]) of beer, 5 oz (148 mL) of wine, or 
1.5 oz (44 mL) of 80-proof distilled spirits (U.S. Department 
of Health and Human Services [USDHHS] 2000). 
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Females Males 
ICD–9 ICD–10 Drinking Category* 
Disease code code I I III I II III 
Malignant neoplasms 140–208 C00–C97 
Mouth and oropharynx cancers 140–149 C00–C14 1.45 1.85 5.39 1.45 1.85 5.39 
Esophagus cancer 150 C15 1.80 2.38 4.36 1.80 2.38 4.36 
Liver cancer 155 C22 1.45 3.03 3.60 1.45 3.03 3.60 
Breast cancer 1.14 1.41 1.59 
Under 45 years of age 174 C50 1.15 1.41 1.46 
45 years and over 1.14 1.38 1.62 
Other neoplasms 210–239 D00–D48 1.10 1.30 1.70 1.10 1.30 1.70 
Diabetes mellitus 250 E10–E14 0.92 0.87 1.13 1.00 0.57 0.73 
Neuropsychiatric conditions 290–319, 
324–359 G06–G98 
Unipolar major depression 300.4 F32–F33 RR not available; AF could not be determined otherwise (Rehm et al., in press b) 
Epilepsy 345 G40–G41 1.34 7.22 7.52 1.23 7.52 6.83 
Alcohol use disorders 291, 303, F10 AF** AF AF AF AF AF 
305.0 100%† 100% 100% 100% 100% 100% 
Cardiovascular diseases (CVD) 390–459 I00–I99 
Hypertensive disease 401–405 I10–I13 1.40 2.00 2.00 1.40 2.00 4.10 
Coronary heart disease 410–414 I20–I25 0.82 0.83 1.12 0.82 0.83 1.00 
Cerebrovascular disease 430–438 I60–I69 
Ischemic stroke 0.52 0.64 1.06 0.94 1.33 1.65 
Hemorrhagic stroke 0.59 0.65 7.98 1.27 2.19 2.38 
Other CVD causes 415–417, 423– I00, I26–I28, 
424, 426–429, I34–I37, I44– 1.50 2.20 2.20 1.50 2.20 2.20 
440–448, 451– I51, I70–I99 
459 
Digestive diseases 530–579 K20–K92 
Cirrhosis of the liver 571 K70, K74 1.26 9.54† 9.54† 1.26 9.54† 9.54† 
NOTE: Relative risk estimates are shown to quantify the effect size of the risk relationships. For example, females in drinking category I have a relative risk of 1.14, com­
pared with female abstainers, of breast cancer. A relative risk of 1.14 corresponds to a 14-percent higher risk. For females in drinking category III, the relative risk is 1.59, 
or about one and one-half times as large as for female abstainers. The same relationship can also be expressed as a risk increase of 59 percent. 
Varying numbers of studies were used to report on the different diseases. Measurement problems for outcomes affected the reliability of the data for some endpoints, 
especially the different subtypes of strokes and the unspecified categories such as “other cardiovascular disease” or “other neoplasms.” The results for these categories 
should be regarded with caution. 
*Definition of drinking categories: 
Category I: for females, 0–19.99 g pure alcohol daily; for males, 0–39.99 g pure alcohol daily 
Category II: for females, 20–39.99 g pure alcohol daily; for males, 40–59.99 g pure alcohol daily 
Category III: for females, 40 g or more pure alcohol; for males, 60 g or more pure alcohol. 
**AF = attributable fraction—that is, the proportion of disease under consideration that is attributable to alcohol. † For liver cirrhosis, a combined estimate was derived for drinking categories II and III. 
SOURCES: Unless otherwise specified, Gutjahr et al. 2001; for breast cancer and stroke, Ridolfo and Stevenson 2001; for hypertension, Corrao et al. 1999; for CHD, 
drinking category III, Corrao et al. 2000. 
Relative Risk for Major Chronic Disease Categories, by Gender and Average Drinking Category 
I
F01–F99, 
associated with lower risk for CHD Rehm et al. 1997), with average con- moderate drinking, including alco­
incidence and mortality, the lowest sumption of more than 70 grams per hol’s role in reducing plaque deposits 
risk being found at 20 grams per day. day associated with greater risk than in arteries and the fact that moderate 
For higher levels of average volume the risks for abstainers. Several physio- alcohol consumption protects against 
of alcohol consumption, the risk rela- logical mechanisms have been suggested blood clot formation and promotes 
tionship reverses (Corrao et al. 2000; to explain the protective effect of blood clot dissolution (Zakhari 1997; 
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confidence intervals. 
NOTE: The middle line represents the result of the meta-analysis; the other two represent the lower and upper 
Example of relationship between average alcohol consumption and CHD, as 
expressed by a J-shaped curve with confidence intervals. 
Rehm et al. 2003, in press b). How-
ever, most of these mechanisms are 
thought to apply only for cohorts in 
which a majority of respondents have 
reported a pattern of regular drinking 
without variability. As most of the 
studies analyzed by Corrao and col­
leagues (2000) used cohorts formed 
by groups with such patterns, further 
research is needed to determine how 
patterns of drinking other than regu­
lar light-to-moderate drinking are 
linked to CHD, especially among 
cohorts of usually light-to-moderate 
drinkers who sometimes binge drink. 
Binge Drinking and CHD. A case 
control study in Australia (McElduff 
and Dobson 1997) compared 11,511 
nonfatal and fatal cases of acute myo­
cardial infarction, or coronary death, 
with 6,077 randomly selected people 
from the general population (i.e., con­
trol subjects). This study confirmed 
the already mentioned protective effect 
of moderate drinking, which was most 
pronounced for regular light-to-moderate 
drinkers. For example, men and women 
who drank one to two drinks per day 
on 5 or 6 days per week had one-third 
the risk of major coronary events com­
pared with those who did not drink at 
all. The risk reduction was still marked 
when former drinkers were excluded. 
However, McElduff and Dobson (1997) 
found that binge drinkers (i.e., women 
who consumed five or more drinks on 
an occasion, or men who consumed 
nine or more drinks on an occasion) 
had higher risks for major coronary 
events than abstainers, even when over-
all volume of drinking was low. More 
recent studies that followed partici­
pants over time (i.e., prospective stud­
ies) also concluded that heavy drinking 
occasions increased the risk of CHD 
even in light-to-moderate drinkers (Mur­
ray et al. 2002; Trevisan et al. 2001a,b). 
This pattern effect persisted after con-
trolling for average volume of drinking. 
Binge Drinking and Other Negative 
Cardiovascular Effects. In addition to 
its effect on CHD, an irregular pat-
tern of heavy drinking occasions 
appears to have a relationship with 
other types of cardiovascular death 
such as stroke or sudden cardiac death 
(e.g., Wannemethee and Shaper 1992; 
Kauhanen et al. 1997). This relation-
ship is consistent with the increased 
clotting and lowered threshold for 
ventricular fibrillation that occur after 
heavy drinking (see reviews by McKee 
and Britton 1998 and Rehm et al. 
2003). (Heavy drinking appears to 
lower the threshold at which the ven­
tricular heart muscle begins a rapid 
contraction pattern; without prompt 
intervention, this pattern prevents 
normal heart function and results in 
death.) Specifically, heavy drinking 
occasions have been shown to increase 
low density lipoproteins, which have 
been linked to negative cardiovascular 
outcomes. Although regular low-to-
moderate drinking is associated with 
an increase in high density lipopro­
teins, which have been linked to 
favorable cardiovascular outcomes, 
this effect is not associated with irreg­
ular heavy drinking occasions (for a 
meta-analysis of the effect of moder­
ate drinking on lipids and other phys­
iological outcomes, see Rimm et al. 
1999). In addition, irregular heavy 
drinking is associated with increased 
risk for the formation of blood clots 
within blood vessels (i.e., thrombosis), 
which occurs at the end of a heavy 
drinking occasion (Renaud and Ruf 
1996). Finally, irregular heavy 
drinkers seem predisposed to struc­
tural (i.e., histological) changes in the 
heart muscle and the adjacent impulse-
conducting system, which regulate the 
threshold for ventricular fibrillation. 
In sum, a pattern of irregular heavy 
drinking occasions is mainly associated 
with physiological mechanisms that 
increase the risk of sudden cardiac 
death and other cardiovascular outcomes, 
whereas regular low-to-moderate 
alcohol consumption is associated 
with physiological mechanisms linked 
to favorable cardiac outcomes (for 
overviews of the effects of drinking 
pattern on CVD, see Puddey et al. 
1999; Rehm et al. 2003). However, 
individual-level epidemiological stud­
ies on the consequences of drinking 
(i.e., studies, such as cohort and case 
control studies, which evaluate groups 
of individuals rather than entire popu­
lations) are still scarce, and at least 
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one of them has found heavy drinking 
occasions to have no detrimental 
effects on morbidity (Murray et al. 
1998). 
Aggregate-Level Studies. Because 
there are few individual-level studies, 
much of the discussion on patterns of 
drinking and outcomes is based on 
aggregate-level studies, which evaluate 
whole populations rather than indi­
vidual study participants. Much of 
this research emerged from the natu­
ral experiment provided by the 
Gorbachev anti-alcohol campaign in 
what was then the Soviet Union. In 
this campaign, all government 
departments were asked to develop 
strategies to reduce alcohol consump­
tion, which was seen as hindering the 
country’s development. Numerous 
measures were implemented to limit 
access to alcohol, including banning 
alcohol at the workplace, limiting 
alcohol sales hours, restricting the 
number of alcohol outlets, reducing 
alcohol production, and increasing 
prices by 25 percent in 1985 alone. 
In addition, the All-Union Voluntary 
Society for the Struggle for Sobriety 
was created in September 1985 to 
raise public awareness and mobilize 
the population (McKee 1999). 
During the period from 1984 to 
1987, when estimated total alcohol 
consumption in the Soviet Union fell 
by about 25 percent (Shkolnikov and 
Nemtsov 1997), age-adjusted male 
deaths from circulatory disease fell by 
9 percent (Leon et al. 1997). Because 
the Soviets did not use the ICD cod­
ing system, the term “circulatory dis­
ease” is used to refer to a category 
roughly equivalent to CVD (see 
Notzon et al. 1998 for a rigorous 
attempt to equate the two systems). 
After the end of the campaign, alco­
hol consumption increased by about 
36 percent (from 1987 to 1993) and 
the circulatory disease death rate rose 
by 29 percent (between 1987 and 
1994) (Leon et al. 1997). 
Although researchers agree that 
changes in alcohol consumption and 
heavy drinking occasions played a role 
in the changes in circulatory mortality 
rates in the Soviet Union, the degree 
of alcohol’s involvement is still ques­
tioned, as many other social changes 
occurred in the late 1980s and early 
1990s. For example, the collapse of 
the Soviet Union contributed to a 
scarcity of medicine for treating hyper-
tension and other forms of heart dis­
ease and to the collapse of the medical 
care infrastructure in general (e.g., 
Bobak and Marmot 1999; Notzon et 
al. 1998; McKee et al. 2001). 
A few other aggregate-level studies 
have examined the influence of 
population-level alcohol consump­
tion on CHD (i.e., ecological stud­
ies). Two studies that compared per 
capita alcohol consumption and CHD 
rates at a series of points in time (i.e., 
time-series analyses) (Hemström 
2001; Skog 1983) failed to find 
effects even for countries where most 
drinking is believed to be regular and 
on average moderate, such as France 
and Italy (but see Gmel et al. 2003a). 
Other research has found that regions 
(e.g., Moscow, Scotland) or groups 
(e.g., German working males) with a 
tradition of heavy drinking or binge 
drinking occasions on weekends show 
disproportionally high CHD mortality 
on Mondays (Willich et al. 1994; 
Chenet et al. 1998; Evans et al. 2000). 
Effect of Drinking With Meals. 
Whether or not one drinks with meals 
has been found to be relevant to CHD. 
Trevisan and colleagues (2001a,b) 
found that people who drank alcohol 
mainly with meals and snacks had con­
sistently lower risks for CHD than 
those who drank at other times, after 
adjustment for age, education, and vol­
ume of alcohol consumed. The mecha­
nisms accounting for this difference in 
risk are still not clear, although a few 
have been proposed. Drinking with 
meals has been found to reduce blood 
pressure (Trevisan et al. 1987; Wu and 
Trevisan 2001; Foppa et al. 1999) and 
to positively affect lipids (Veenstra et al. 
1990) and the dissolution of blood clots 
(Hendriks et al. 1994). In addition, the 
presence of food in the gastrointestinal 
tract may reduce alcohol absorption 
(Gentry 2000) or increase the rate at 
which alcohol is eliminated from the 
body (Ramchandani et al. 2001). 
Beverage-Specific Effects. Researchers 
have long proposed that rates of 
CHD vary depending on the bever­
age consumed, ascribing a special 
beneficial effect to red wine. However, 
Rimm and colleagues (1996) reviewed 
the literature with respect to beverage-
specific effects on CHD and did not 
find any systematic evidence that the 
protective effect was caused by or 
more prominent for any kind of bev­
erage. Although many additional 
publications on this topic have ap­
peared since their review, no consis­
tent pattern of results has emerged. It 
is notable that researchers have found 
protective effects in Bavaria (Keil et 
al. 1997) and the Czech Republic 
(Bobak et al. 2000) similar to those 
effects found in Mediterranean coun­
tries. In Bavaria and the Czech Re-
public, beer is consumed the way wine 
is consumed in Mediterranean coun­
tries: regularly, on an almost daily basis, 
with meals. The study found that the 
manner of consumption was more 
important than the type of beverage. 
The overall problem with studying 
beverage-specific effects is that beverage 
preference in most cultures is linked 
with other variables such as socioeco­
nomic status and lifestyle variables (e.g., 
Bondy and Rehm 1998). These link-
ages may not be the same for differ­
ent cultures, but many countries 
show clear covariation. For example, 
wine drinking in beer cultures is often 
associated with middle- and upper-
class lifestyles. This makes it almost 
impossible to separate the effects of 
the beverages from other effects. 
Conclusions on Alcohol and CHD. 
What conclusions can be reached 
regarding the relationship between 
alcohol consumption and CHD? 
First, the physiological, individual-
level, and aggregate-level research con-
verges to demonstrate the detrimental 
effect of irregular heavy drinking 
occasions. Both case control and 
cohort studies have supported this 
detrimental effect, and it has been 
corroborated by research using the 
natural experiment of the Gorbachev 
campaign. The result of irregular 
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heavy drinking also has plausible 
physiological pathways. 
Evidence that regular light-to-
moderate drinking has a beneficial 
effect on the cardiovascular system 
comes from physiological and individual-
level epidemiological studies. How-
ever, aggregate-level, time-series anal­
yses have failed to confirm this effect. 
Reasons for the different results for 
the two kinds of analyses are unknown. 
The time-series analyses may have 
been confounded by methodological 
problems, including a relatively short 
time period (Rehm and Gmel 2001; 
see also Hatanaka 1996; Greene 2000; 
Yaffee 2000). Ecological studies also 
have general limitations in elucidat­
ing causality. In contrast, the individ­
ual-level studies are based on stronger 
methodology. The accompanying 
sidebar reviews a number of method­
ological issues relevant to studies of 
alcohol-related morbidity and mortality. 
Alcohol Consumption and Cancer 
Many studies have reported consistent 
relationships between average con­
sumption of alcohol and different 
types of cancer. (For examples of spe­
cific meta-analyses in the last five 
years in addition to the overviews of 
all alcohol-related conditions, see 
Bagnardi et al. 2001a,b; Dennis 2000; 
Ellison et al. 2001; Smith-Warner et 
al. 1998; Zeegers et al. 1999.) A recent 
series of meta-analyses showed that 
drinking on average 25 grams of pure 
alcohol per day was associated with sig­
nificantly elevated cancer risks for the 
following sites: oral cavity and pharynx, 
esophagus, stomach, colon and rectum, 
liver, larynx, and female breast (Bag­
nardi et al. 2001a,b). However, for 
many cancer sites, even though there is 
a consistent relationship between aver-
age consumption of alcohol and risk 
for cancer, other criteria for determin­
ing causality are lacking. For example, 
for lung cancer, after adjusting for 
smoking, one meta-analysis showed a 
consistent effect with a relatively large 
effect size (English et al. 1995). How-
ever, because evidence for the possible 
biological mechanism was not conclu­
sive and residual confounding from 
smoking could not be excluded, the 
authors excluded lung cancer from the 
list of diseases influenced by alcohol. 
A later meta-analysis showed only 
borderline significant effects (Bagnardi 
et al. 2001a,b), and the most recent 
review concluded that the evidence for 
a causal relationship was not sufficient 
(Bandera et al. 2001). Using consistent 
criteria, Rehm and colleagues (in press 
a) concluded that sufficient evidence of 
causality existed for the following can­
cer sites: oral cavity and pharynx, eso­
phagus, liver, larynx, and female breast. 
Other Major Chronic Health 
Consequences of Alcohol Use 
Alcohol use is also related to chronic 
health consequences other than CVD 
and cancer. Most notable are neuro­
psychiatric and digestive diseases. The 
causal role of alcohol use in alcohol 
use disorders (e.g., alcohol dependence, 
alcohol abuse) is obvious. Alcohol use 
disorders are responsible for a consid­
erable burden of disease in the United 
States and worldwide (e.g., Michaud 
et al. 2001). Moreover, alcohol use may 
cause depression (see Rehm et al. in 
press b). The fact that alcohol causes 
depression in some people does not 
exclude the possibility that some alcohol 
use disorders are caused by depression, 
or that, for some people with comorbid 
depression and alcohol use disorders, 
there may be a third cause. On the 
contrary, all three causal pathways 
seem to exist. 
The association between alcohol 
use and liver cirrhosis is well estab­
lished (e.g., Rodés et al. 1999). Re-
searchers have considered whether ir­
regular heavy drinking is a specific 
contributing factor to cirrhosis, in 
addition to the well-established rela­
tionship between cirrhosis and overall 
volume of drinking (Kozarevic et al. 
1983; Rodés et al. 1999). 
Acute Consequences of 
Alcohol Use 
Alcohol use has been associated with 
increased risk of injury in a wide vari­
ety of situations including motor 
vehicle crashes, bicycling accidents, 
incidents involving pedestrians, falls, 
fires, injuries in sports and recreational 
activities, interpersonal violence, 
and self-inflicted injuries (Cherpitel 
1992; Hingson and Howland 1987, 
1993; U.S. Department of Health 
and Human Services [USDHHS] 
1997, 2000; Martin 1982, Martin 
and Bachman 1997; Freedland et al. 
1993; Hurst et al. 1994). Some evi­
dence from emergency room studies 
and police records also suggests that 
the presence of alcohol in the body at 
the time of injury may be associated 
with greater severity of injury and less 
positive outcomes (Fuller 1995; Li et 
al. 1997). Overall, morbidity and 
mortality from traumatic injury is by 
far the most important health conse­
quence of alcohol use in developed 
countries such as Canada or the 
United States (Single et al. 1999). 
This section highlights research 
examining the relationships between 
acute health consequences and both 
average volume of alcohol consumption 
and drinking patterns. It focuses on 
unintentional injuries—specifically, 
traffic injuries—because most of the 
relevant research has been conducted in 
this area and because traffic crashes 
account for most alcohol-related unin­
tentional injuries. For additional infor­
mation on the relationship between 
alcohol and injuries, see the article by 
Gmel and Rehm in this issue. 
Research has shown that risk of 
injury is positively related to average 
intake of alcohol, and that injury 
risk starts increasing at relatively low 
volumes of alcohol consumption 
(e.g., Cherpitel et al. 1995). Two 
studies of injury among adults ages 
51 through 61 reported a U-shaped 
relationship between alcohol use 
and occupational injury (Zwerling 
et al. 1996) and traumatic deaths 
(Ross et al. 1990). That is, the rate 
of injury and death was higher among 
people who abstained from alcohol 
than among those who drank small-
to-moderate amounts. The rate 
increased again with increasing alcohol 
use. This pattern may be explained by 
the fact that people who abstain 
(Continued on page 48) 
44 Alcohol Research & Health 
The relationships between alcohol consumption and dis­
ease outcomes have been reported in the alcohol literature 
based on the best available epidemiological evidence. 
However, this evidence is to some extent open to ques­
tion because of the methodological limitations of the 
studies that produced it, particularly in relation to: 
• Measurement of alcohol consumption and theo­
rized exposure 
• Measurement of outcome 
• Selection of a comparison group 
• Design-specific issues. 
(See also Rehm and Gmel 2003.) 
Measurement of Alcohol Consumption and 
Theorized Exposure 
For individual-level epidemiological studies, alcohol 
consumption is usually determined using quantity 
and frequency (QF) measures. These measures 
markedly underestimate the volume of drinking in 
developed countries (e.g., Midanik 1988, 1989; 
Rehm 1998). Thus, it is problematic to take them at 
face value—that is, to use them to derive risk relation-
ships that state the risk related to the consumption of 
a certain volume of alcohol (e.g., grams of pure alco­
hol). Although no simple solution to this measure­
ment problem exists, alcohol epidemiology has devel­
oped better ways to measure alcohol consumption, 
including measures of both volume of drinking at a 
certain point in time (e.g., during the last month) and 
volume accumulated over a longer period, such as the 
previous 5 years or the entire lifetime. Such measures 
may be necessary for estimating the associations with 
chronic diseases such as cancer. 
One of these improved measures is the graduated 
frequency (GF) method, which asks respondents how 
often they consumed specific quantities, such as 10 to 
12 drinks, in a given time period (Greenfield 2000). 
GF measures have been shown to underestimate volume 
of alcohol consumed to a smaller degree (Midanik 
1994) than quantity and frequency measures and to 
correlate better with medical outcomes (Rehm et al. 
1999b). The graduated frequency method also allows 
researchers to measure irregular heavy drinking patterns 
as well as volume of drinking at a certain point in time 
(Greenfield 2000; Rehm 2000). Thus, GF measures 
seem preferable to the QF measures currently used in 
medical epidemiology. However, it should be stressed 
that the method of measuring alcohol consumption 
used in an epidemiological study should be determined 
by the theoretically postulated relationship between 
drinking and disease, and based on the drinking pat-
terns in the culture studied. 
The relationship between alcohol consumption 
and outcome is often based on outcomes assessed at fol­
lowup, often years after the baseline assessment, with 
analysis to adjust for the effects of several potential 
confounder variables such as smoking, age, or socio­
economic status. These procedures must assume that 
the baseline variables are stable over time, and that 
they are good indicators of the proposed relationship 
between alcohol consumption and disease (Sempos et 
al. 1993). For example, in assessing the relationship 
between average volume of alcohol consumption and 
incidence of breast cancer, it must be assumed that 
heavy consumption persists after baseline and is a 
good indicator of overall tissue exposure, which is the 
theoretical risk factor for breast cancer. If an association 
between two variables, such as heavy drinking and 
breast cancer, is real, any errors in measuring exposure 
will “dilute” the strength of the relationship. 
Therefore, the size of the real effects is often under-
estimated because of the inaccurate measurement of 
alcohol consumption at baseline (Clarke et al. 1999). 
One way to avoid this dilemma is to use measures 
such as lifetime drinking history in addition to point 
measures (Russell et al. 1997). The lifetime drinking 
history is clearly capable of yielding a closer approxi­
mation of a theorized lifetime cumulative exposure, 
which is essential when studying chronic diseases for 
which accumulated volume of alcohol consumption is 
the important factor in risk. 
For acute outcomes, the usual quantity and fre­
quency measures also do not correspond to the theo­
retical exposure, which may be BAC or intoxication 
before the event (e.g., Rossow et al. 2001). Here, 
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objectively measuring BAC or asking directly for 
degree of intoxication would be preferred options. 
Although this sidebar does not review all possible 
means of measuring alcohol consumption, the examples 
given should suffice to make the point that the mea­
sure of alcohol consumption used in epidemiological 
studies should reflect the theory underlying the research. 
Measurement of Outcome 
Mortality can usually be measured with relatively little 
error. Morbidity is more problematic. 
On the one hand, many medical epidemiological 
studies take pains to objectively assess and validate the 
outcome under consideration. Examples include two 
coronary heart disease (CHD) studies, the National 
Health and Nutrition Examination Survey I (NHANES I) 
followup study on CHD incidence (Sempos et al. 
1994), and the World Health Organization MONItoring 
Trends and Determinants in CArdiovascular Diseases 
(MONICA) study, a long-term, multinational study 
on CHD (Tunstall-Pedoe et al. 1999). 
On the other hand, studies based on alcohol sur­
veys often measure morbidity by self-assessment, 
sometimes even including an attribution of causality in 
the questions respondents are asked (e.g., “Was there 
ever a time when you felt your alcohol use had a 
harmful effect on your physical health?”). It is impossi­
ble to establish causal relationships with these types of 
questions (Rehm et al. 1999a; Gmel et al. 2000). It is 
not even possible to establish correlation based on the 
results of such surveys, beyond the fact that people sub­
jectively believe that there is a relationship between 
alcohol use and health outcomes. The history of med­
icine has often shown that such subjective assessment of 
causality and correlation may not be valid. For instance, 
women with breast cancer have subjectively attributed 
their cancer to their number of sexual partners, a causal 
relation that has no objective basis (Geyer 2000). Simi­
larly, people may attribute health and other problems to 
alcohol in cases where there is no real relationship. As a 
consequence, future studies linking alcohol and disease 
should try to combine the rigorous objective assessment of 
outcomes used in medical epidemiology with state-of-
the-art measurement of alcohol epidemiology. 
Selection of a Comparison Group 
Studies of alcohol-related health outcomes often use 
abstainers as a comparison group. Abstainers, how-
ever, are not a homogeneous group, at least in devel­
oped countries. Many people stop drinking because 
they have become sick, thus increasing the relation-
ship between abstention and disease (Shaper 1990). 
Studies of disease risk that compare different levels of 
drinking and no drinking may overestimate the pro­
tective effect of light-to-moderate drinking if abstain­
ers are not separated into lifetime abstainers and for­
mer drinkers (Rehm et al. 2001). For example, when 
the relationship between alcohol use and disease 
forms a J-shaped curve (see the figure in the article), 
the increased risk observed for abstainers may reflect 
the fact that some former drinkers became current 
abstainers because of health problems. Even if this dis­
tinction is made, interpreting risk differences for cur-
rent drinkers compared with lifetime abstainers may be 
difficult, because lifetime abstainers in many societies 
differ from the general population in several other 
ways, such as diet, religion, or socioeconomic status 
(e.g., Bondy and Rehm 1998). Because long-term 
studies cannot manipulate abstention status experimen­
tally, there is no final way to determine the causal influ­
ence of alcohol consumption. However, statistical con­
trol of potential confounders is possible. 
Design-Specific Issues 
Of the two major categories of research designs, 
individual-level studies produce results that deserve 
greater attention than the results of aggregate-level, or 
ecological, studies, especially when the individual-level 
results are corroborated by evidence from physiological 
experiments. However, specific aggregate-level examples 
with interventions, such as the study of the Gorbachev 
anti-alcohol campaign (described in the article), play 
an important role in alcohol epidemiology. 
The Gorbachev campaign is an exception for several 
reasons: It was a natural experiment with a purposeful 
change in one variable; it affected a large outcome cat­
egory (mortality from all causes); its effects cannot be 
explained by changes in the system used to document 
causes of death or other changes; and it had very large 
effects. Other ecological analyses in the alcohol field 
tend to show correlations over time or countries, 
which can hardly be interpreted because confounding 
cannot be excluded. 
Generally, however, more value is placed on 
individual-level analysis than on ecological analysis. 
The two individual-level designs most often used are 
case control and cohort designs. Cohort studies may 
be especially problematic in alcohol epidemiology. 
First, many large-scale cohorts are selected in a way to 
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minimize dropouts (i.e., based on their members’ avail-
ability for repeated followups). As a result, nurses, doc-
tors, and other health professionals often make up 
these cohorts. Selecting cohorts on this basis reduces 
the variation within cohorts with respect to alcohol 
consumption. As a consequence, the effects of certain 
drinking patterns cannot be explored in such cohorts. 
Some cohort studies—such as the American Cancer 
Society’s Cancer Prevention Study II, a nonrepresentative 
general population study based on the American Cancer 
Society’s members and friends (Thun et al. 1997)— 
make use of a wider range of drinking styles. These 
cohort studies, however, do not include some patterns 
of drinking that are customary in other parts of the 
world or in other U.S. population subgroups (e.g., 
Native Americans, the homeless, and other disadvan­
taged groups), and thus the effects of these drinking 
patterns cannot be studied. These limitations of cohort 
studies for use in alcohol epidemiology are purely prac­
tical and do not change the theoretical advantages of 
cohorts over case control studies. However, if the rele­
vant behavior is not present in a cohort, no conclusions 
can be drawn. In sum, in many cohorts studied in med­
ical epidemiology, certain patterns are either not repre­
sented or represented in a manner that does not allow 
for analysis. Thus, future cohort studies should include 
people with more varied consumption patterns, such as 
irregular heavy drinking. 
—Jürgen Rehm, Gerhard Gmel, Christopher T. Sempos, 
and Maurizio Trevisan 
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(Continued from page 44) 
from alcohol may have existing health 
problems or cognitive deficits that are, 
in turn, related to injury risk (Zwerling 
et al. 1996). 
Several patterns of drinking have 
been related to injury risk. Frequent 
heavy drinking and frequent drunk­
enness are both associated with 
injury, particularly injury resulting 
from violence (Cherpitel 1996). 
Frequency of heavy drinking has also 
been associated with a greater likeli­
hood of death from injury than from 
other causes (Li et al. 1994). 
Research has also found that peo­
ple who consume relatively large 
amounts of alcohol on some occasions 
and whose highest amounts are marked­
ly greater than their average amount 
per occasion have the greatest risk for 
injury related to drinking and driving 
(Gruenewald and Nephew 1994; 
Gruenewald et al. 1996a,b; Treno and 
Holder 1997; Treno et al. 1997). 
A series of retrospective case control 
studies have compared the blood alco­
hol concentration (BAC) levels of peo­
ple who had experienced trauma (i.e., 
traffic crashes or other incidents) with 
the BAC levels of people, usually from 
the general population, who were not 
involved in trauma (Cherpitel 1992; 
Freedland et al. 1993; Fuller 1995; 
Stoduto et al. 1993; USDHHS 1997; 
Hurst et al. 1994). In the largest such 
study, Borkenstein and colleagues 
(1964) compared the BAC levels of 
5,985 drivers involved in traffic crash­
es with those of 7,590 control drivers 
in Grand Rapids, Michigan, in 1962 
and 1963. For the control sample, 
police stopped vehicles at preselected 
sites and times, after which members 
of the research team requested a vol­
untary breath sample exclusively for 
research purposes. A proper statistical 
analysis of this study (Hurst et al. 
1994) found that all levels of BAC 
were associated with a higher risk of 
crashes, relative to a BAC of zero, and 
that the risk of injury increased expo­
nentially with markedly higher BACs. 
There are clear reasons why alcohol 
is related to all kinds of trauma and 
injury. Even moderate doses of alcohol 
have cognitive and psychomotor 
effects that are relevant to the risk of 
injury, such as effects on reaction time, 
cognitive processing, coordination, 
and vigilance (Moskowitz and Robinson 
1988; USDHHS 1997; Krüger et al. 
1993; Eckardt et al. 1998). Eckardt 
and colleagues (1998) concluded that 
the threshold for negative effects on 
psychomotor tasks is generally found 
around 0.04 to 0.05 percent BAC. 
Driving experience diminishes the 
adverse impact of alcohol on perfor­
mance (Preusser et al. 1978). Research 
has also shown that the relative risk 
of a fatal crash increases with increas­
ing BAC for each age group but that 
fatal crash risk for drivers ages 16 to 
19 years is higher than the risk for 
other age groups at all BACs, includ­
ing zero. This is a result of younger 
drivers’ lower tolerance for alcohol 
and their relative inexperience in 
driving (Mayhew et al. 1985, 1986; 
Zador 1991). 
Dose-response relationships 
observed in experimental data are not 
always linear. For example, a recent 
study with human participants (Lloyd 
and Rogers 1997) assessed the effects 
of low doses of alcohol given with a 
meal and found that a dose of 8 
grams of pure alcohol resulted in 
improved performance on a complex 
cognitive task in comparison with no 
alcohol intake, but that 24 grams of 
alcohol produced impaired perfor­
mance (Eckardt et al. 1998). 
In summary, the evidence indicates 
that the amount of alcohol consumed 
per occasion—specifically, the BAC— 
is the critical feature in determining risk 
of injury. BACs as low as 0.04 to 0.05 
percent may cause psychomotor 
impairments that lead to increased risk 
of injury while driving or operating 
machinery. Alcohol use can be estab­
lished as a contributing factor in traffic 
crashes for the following reasons: 
•	 Alcohol is clearly associated with the 
outcome (i.e., consumption of alco­
hol increases the risk of being 
involved in traffic crashes). 
•	 There is a dose-response relation-
ship: the higher the BAC, the 
higher the chance for injury. 
•	 There is physiological evidence for 
the relationship. 
• Interventions that reduce drinking 
and driving also reduce alcohol-
related traffic crashes. For example, 
Shults and colleagues (2001) re-
ported in a meta-analysis that ran­
dom breath testing programs or 
selective breath testing checkpoints 
were effective in reducing the mor­
tality of traffic crashes by 18 percent 
and the number of fatal crashes by 
20 percent, in comparison with 
locations that did not have such 
programs or checkpoints. 
Establishing causality for other 
forms of alcohol-related injuries is 
more difficult, even though a strong 
link may exist. Further research is 
needed in this area. 
Alcohol and Summary 
Measures of Health 
This article has reviewed research on 
the observed relationships between 
alcohol consumption and disease. 
Many relationships exist, both detri­
mental and beneficial. This section will 
review what is known about alcohol 
and summary measures of health, 
which are measures that give a general 
picture of the health of a population, 
rather than any specific disease risk. One 
classic summary measure is mortality 
from all causes. The relationship 
between average volume of consump­
tion and all-cause mortality in males 
and females older than 45 is J-shaped, 
as evidenced by recent meta-analyses 
(English et al. 1995; Rehm et al. 
2001b; Gmel et al. 2003b). In younger 
cohorts, a linear relationship prevails— 
that is, light-to-moderate drinking has 
no protective effect (Rehm et al. 
2001b). Indications are that pattern of 
drinking influences all-cause mortality 
in all ages as well (Rehm et al. 2001a). 
All-cause mortality may not, how-
ever, be the best summary indicator 
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for measuring alcohol’s impact on 
health. As indicated above, alcohol 
use has stronger links to morbidity 
and disability than to mortality 
(Murray and Lopez 1997). Thus, a 
suitable summary indicator (Murray 
et al. 2000) should integrate data on 
mortality, morbidity, and disability. 
Such a summary indicator should 
also be based on a time measure, such 
as years of life lost. The Disability 
Adjusted Life Year (DALY) concept 
fulfills these requirements ideally. It is 
a measure that combines years of life 
lost because of early mortality (i.e., 
death before the life expectancy in the 
country with the highest life expec­
tancy worldwide [currently Japan]) 
with years of life lost to imperfect 
health (Murray et al. 2000). The rela­
tionship between alcohol consump­
tion and DALYs demonstrates that a 
substantial burden of disease is attri­
butable to alcohol consumption. In 
1990 this was estimated as globally 
higher than the burden of disease 
attributable to tobacco, even after 
subtracting the beneficial effects on 
CHD (Murray and Lopez 1996, 1997). 
Conclusion 
Alcohol use is related to a huge health 
burden in the United States and most 
countries worldwide, even after dis­
counting for its beneficial effects. In 
considering this burden, especially for 
chronic disease, one must keep in 
mind the limitations of epidemiologi­
cal studies, which are mostly observa­
tional in nature (e.g., cohort studies 
and case control studies, as described 
above; also see the sidebar). However, 
most of the relationships between 
alcohol use and disease outcomes 
have also been corroborated by exper­
imental physiological research. 
Much of the alcohol-related health 
burden could be avoided by initiating 
or strengthening policy measures 
proven to be effective in reducing 
alcohol use and related problems, 
such as taxing consumption, restrict­
ing access to alcohol, and random 
breath testing (Edwards et al. 1994). 
Some of these measures (e.g., taxa­
tion, restricting access) have been 
shown to reduce the social harm 
caused by alcohol consumption as 
well. Given the size of the burden of 
disease related to alcohol use and the 
availability of effective countermea­
sures, there seems to be no justifica­
tion for continuing the status quo. ■ 
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